Medtronic (NYSE:MDT) announced that it inaugurated a new Diabetes Global Capability Center in India with a significant investment.
Our sister site, Drug Delivery Business News, reports today that the medtech giant said it plans to invest $50 million over five years in the Pune, India location. It also said the investment reflects its long-term commitment to India’s healthcare ecosystem.
Medtronic expects the center to create 300 new jobs in its first year. Beyond that, the company has plans to expand further in the years ahead. That includes across capabilities like patient financial services, digital technology, customer care and advanced analytics.
The investment in a diabetes-related center comes at an interesting time for Medtronic, which announced last month that it planned to separate the Diabetes unit.
Get the full story at our sister site, Drug Delivery Business News.
